Cargando…

How we treat primary immune thrombocytopenia in adults

Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder characterized by decreased platelet counts and an increased risk of bleeding. Multiple humoral and cellular immune abnormalities result in accelerated platelet destruction and suppressed platelet production in ITP. The dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xin-guang, Hou, Yu, Hou, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850343/ https://www.ncbi.nlm.nih.gov/pubmed/36658588 http://dx.doi.org/10.1186/s13045-023-01401-z

Ejemplares similares

Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
por: Liu, Xin-guang, et al.
Publicado: (2016)

Clonal hematopoiesis in primary immune thrombocytopenia
por: Wang, Yanming, et al.
Publicado: (2022)

T cell immune abnormalities in immune thrombocytopenia
por: Ji, Xuebin, et al.
Publicado: (2014)

Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia
por: Yu, Tian-shu, et al.
Publicado: (2021)

Disrupted balance of CD4(+) T-cell subsets in bone marrow of patients with primary immune thrombocytopenia
por: Wang, Qian, et al.
Publicado: (2019)

High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia
por: Wang, Xinru, et al.
Publicado: (2019)

Immune Checkpoint-Related Gene Polymorphisms Are Associated With Primary Immune Thrombocytopenia
por: Wang, Shuwen, et al.
Publicado: (2021)

Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: A systematic review and network meta-analysis
por: Wang, Yun, et al.
Publicado: (2022)

Current Management of Primary Immune Thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2015)

Inflammation-Related Gene Polymorphisms Associated With Primary Immune Thrombocytopenia
por: Li, Ju, et al.
Publicado: (2017)

Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
por: Mei, Heng, et al.
Publicado: (2023)

How we treat endocrine complications of immune checkpoint inhibitors
por: Paschou, S.A., et al.
Publicado: (2021)

Increased Number of Tc17 and Correlation with Th17 Cells in Patients with Immune Thrombocytopenia
por: Hu, Yu, et al.
Publicado: (2011)

Efgartigimod alfa for the treatment of primary immune thrombocytopenia
por: Broome, Catherine
Publicado: (2023)

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
por: Tomasello, Riccardo, et al.
Publicado: (2021)

Hyperlipidemia in immune thrombocytopenia: a retrospective study
por: Han, Shouqing, et al.
Publicado: (2023)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

How we treat medulloblastoma in adults
por: Franceschi, E., et al.
Publicado: (2021)

How we treat neurological toxicity from immune checkpoint inhibitors
por: Spain, Lavinia, et al.
Publicado: (2019)

Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?
por: Visweshwar, Nathan, et al.
Publicado: (2022)

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
por: Crickx, Etienne, et al.
Publicado: (2023)

Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia
por: Tan, Jian Hong, et al.
Publicado: (2023)

Biomarkers for immune thrombocytopenia
por: Yu, Lingjia, et al.
Publicado: (2015)

How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors
por: Jordan, B., et al.
Publicado: (2021)

How we treat locoregional melanoma
por: Troiani, T., et al.
Publicado: (2021)

Adolescents and young adults with newly diagnosed primary immune thrombocytopenia
por: Schifferli, Alexandra, et al.
Publicado: (2023)

Recent advances in treatments of adult immune thrombocytopenia
por: Kim, Dae Sik
Publicado: (2022)

Evolving treatment modalities for immune thrombocytopenia in adults
por: Khadka, Sushmita, et al.
Publicado: (2021)

Should we treat pyrexia? And how do we do it?
por: Doyle, James F., et al.
Publicado: (2016)

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
por: von Lukowicz, Hannah, et al.
Publicado: (2021)

Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation
por: Qu, Mingming, et al.
Publicado: (2018)

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
por: Janssens, Ann, et al.
Publicado: (2016)

Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
por: Singh, Anurag, et al.
Publicado: (2021)

Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia
por: Han, Panpan, et al.
Publicado: (2021)

A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia
por: Chen, Dandan, et al.
Publicado: (2022)

P1595: ACTIVATION OF CHAPERONE-MEDIATED AUTOPHAGY REDUCES NLRP3 AND PLATELET CLEARANCE IN IMMUNE THROMBOCYTOPENIA
por: Xu, Yitong, et al.
Publicado: (2023)

How we treat metastatic colorectal cancer
por: De Falco, Vincenzo, et al.
Publicado: (2020)

How we treat patients with leptomeningeal metastases
por: Le Rhun, Emilie, et al.
Publicado: (2019)

How we treat NK/T-cell lymphomas
por: Tse, Eric, et al.
Publicado: (2022)

P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
por: Zhou, Hu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hjmp64tjn3dubvo2eq0ofkq9bl